 | • レポートコード：360iR22NB033 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の調査レポートでは、世界の空間オミックス市場規模が2021年の414.49百万ドルから、2022年に464.38百万ドルに達すると予測しています。今後、2027年まで年平均12.61%で、845.58百万ドルまでに成長する見込みです。本市場調査資料では、空間オミックスの世界市場を調査対象とし、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別（ゲノミクス、プロテオミクス、トランスクリプトミクス）分析、サンプルタイプ別（ホルマリン固定パラフィン包埋（FFPE）、新鮮凍結）分析、製品別（消耗品、器具、ソフトウエア）分析、ワークフロー別（データ分析、機器分析、サンプル調製）分析、エンドユーザー別（学術・トランスレーショナルリサーチ機関、製薬・バイオテクノロジー企業）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを整理しました。本書では10x Genomics, Inc.、Akoya Biosciences, Inc.、Bio-Techne Corporation、Biognosys AG、BioSpyder Technologies Inc.、Bruker Corporation、Danaher Corporation、Dovetail Genomics, LLC、Fluidigm Corporation、IonPath, Inc.、NanoString Technologies, Inc.、PerkinElmer, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の空間オミックス市場規模：技術別 - ゲノミクス式空間オミックスの市場規模 - プロテオミクス式空間オミックスの市場規模 - トランスクリプトミクス式空間オミックスの市場規模 ・世界の空間オミックス市場規模：サンプルタイプ別 - ホルマリン固定パラフィン包埋（FFPE）式空間オミックスの市場規模 - 新鮮凍結式空間オミックスの市場規模 ・世界の空間オミックス市場規模：製品別 - 空間オミックス消耗品の市場規模 - 空間オミックス器具の市場規模 - 空間オミックスソフトウエアの市場規模 ・世界の空間オミックス市場規模：ワークフロー別 - データ分析の市場規模 - 機器分析の市場規模 - サンプル調製の市場規模 ・世界の空間オミックス市場規模：エンドユーザー別 - 学術・トランスレーショナルリサーチ機関の市場規模 - 製薬・バイオテクノロジー企業の市場規模 ・世界の空間オミックス市場規模：地域別 - 南北アメリカの空間オミックス市場規模 アメリカの空間オミックス市場規模 カナダの空間オミックス市場規模 ブラジルの空間オミックス市場規模 ... - アジア太平洋の空間オミックス市場規模 日本の空間オミックス市場規模 中国の空間オミックス市場規模 インドの空間オミックス市場規模 韓国の空間オミックス市場規模 台湾の空間オミックス市場規模 ... - ヨーロッパ/中東/アフリカの空間オミックス市場規模 イギリスの空間オミックス市場規模 ドイツの空間オミックス市場規模 フランスの空間オミックス市場規模 ロシアの空間オミックス市場規模 ... - その他地域の空間オミックス市場規模 ・競争状況 ・企業情報 |
The Global Spatial OMICS Market size was estimated at USD 414.49 million in 2021 and expected to reach USD 464.38 million in 2022, and is projected to grow at a CAGR 12.61% to reach USD 845.58 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Spatial OMICS to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Genomics, Proteomics, and Transcriptomics.
Based on Sample Type, the market was studied across FFPE and Fresh Frozen.
Based on Product, the market was studied across Consumables, Instruments, and Software. The Instruments is further studied across Flow Cytometry, IHC, Mass Spectrometry, Microscopy, and Sequencing Platforms. The Software is further studied across Bioinformatics Tools, Imaging Tools, and Storage & Management Databases.
Based on Workflow, the market was studied across Data Analysis, Instrumental Analysis, and Sample Preparation.
Based on End-use, the market was studied across Academic & Translational Research Institutes and Pharmaceutical and Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Spatial OMICS market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spatial OMICS Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spatial OMICS Market, including 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC, Fluidigm Corporation, IonPath, Inc., NanoString Technologies, Inc., PerkinElmer, Inc., Rebus Biosystems, Inc., S2 Genomics, Inc., Seven Bridges Genomics Inc, Ultivue, Inc., and Vizgen, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Spatial OMICS Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spatial OMICS Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spatial OMICS Market?
4. What is the competitive strategic window for opportunities in the Global Spatial OMICS Market?
5. What are the technology trends and regulatory frameworks in the Global Spatial OMICS Market?
6. What is the market share of the leading vendors in the Global Spatial OMICS Market?
7. What modes and strategic moves are considered suitable for entering the Global Spatial OMICS Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid Advances in the Sequencing of Tissues, Genes, and Single Cell
5.1.1.2. Rise in Government Support for Genomics and Sequencing Technologies
5.1.1.3. Increasing Demand for Personalized Medicine
5.1.2. Restraints
5.1.2.1. Slow Implementation of Technology
5.1.3. Opportunities
5.1.3.1. Gradual Development of Novel Technologies for Spatial OMICS
5.1.3.2. Rising Focusing on New Approaches for Increasing the Application of FFPE in Spatial Transcriptomic Studies Owing to Presence of Substantial Research Organizations
5.1.4. Challenges
5.1.4.1. Challenges Pertaining to the Single-Cell Transcriptomics
5.2. Cumulative Impact of COVID-19
6. Spatial OMICS Market, by Technology
6.1. Introduction
6.2. Genomics
6.3. Proteomics
6.4. Transcriptomics
7. Spatial OMICS Market, by Sample Type
7.1. Introduction
7.2. FFPE
7.3. Fresh Frozen
8. Spatial OMICS Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Instruments
8.4.1. Flow Cytometry
8.4.2. IHC
8.4.3. Mass Spectrometry
8.4.4. Microscopy
8.4.5. Sequencing Platforms
8.4. Software
8.5.1. Bioinformatics Tools
8.5.2. Imaging Tools
8.5.3. Storage & Management Databases
9. Spatial OMICS Market, by Workflow
9.1. Introduction
9.2. Data Analysis
9.3. Instrumental Analysis
9.4. Sample Preparation
10. Spatial OMICS Market, by End-use
10.1. Introduction
10.2. Academic & Translational Research Institutes
10.3. Pharmaceutical and Biotechnology Companies
11. Americas Spatial OMICS Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Spatial OMICS Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Spatial OMICS Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. 10x Genomics, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Akoya Biosciences, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bio-Techne Corporation
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Biognosys AG
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. BioSpyder Technologies Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Bruker Corporation
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Danaher Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Dovetail Genomics, LLC
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Fluidigm Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. IonPath, Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. NanoString Technologies, Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. PerkinElmer, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Rebus Biosystems, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. S2 Genomics, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Seven Bridges Genomics Inc
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Ultivue, Inc.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Vizgen, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing